0001209191-21-037188.txt : 20210602
0001209191-21-037188.hdr.sgml : 20210602
20210602163039
ACCESSION NUMBER: 0001209191-21-037188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEDLEY MARK B
CENTRAL INDEX KEY: 0001863028
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 21989536
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-01
0
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001863028
MEDLEY MARK B
4000 MERIDIAN BLVD
FRANKLIN
TN
37067
0
1
0
0
Regional President
Common Stock
2021-06-01
4
F
0
1163
16.18
D
38645
D
Performance Based Restricted
0.00
Common Stock
15000
15000
D
Performance Based Restricted
0.00
Common Stock
15000
15000
D
Stock Options (Right to Buy)
2.66
2020-06-01
2029-05-31
Common Stock
12000
12000
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
15000
15000
D
Stock Options (Right to Buy)
8.81
2022-03-01
2031-02-28
Common Stock
15000
15000
D
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
Christopher G. Cobb, Attorney in Fact for Mark B Medley
2021-06-02